BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 25948406)

  • 1. Correction. Protocol investigating the clinical utility of an objective measure of activity and attention (QbTest) on diagnostic and treatment decision-making in children and young people with ADHD - 'Assessing QbTest Utility in ADHD' (AQUA): a randomised controlled trial.
    Hall CL; Walker GM; Valentine AZ
    BMJ Open; 2015 May; 5(5):e006838corr1. PubMed ID: 25948406
    [No Abstract]   [Full Text] [Related]  

  • 2. Protocol investigating the clinical utility of an objective measure of activity and attention (QbTest) on diagnostic and treatment decision-making in children and young people with ADHD-'Assessing QbTest Utility in ADHD' (AQUA): a randomised controlled trial.
    Hall CL; Walker GM; Valentine AZ; Guo B; Kaylor-Hughes C; James M; Daley D; Sayal K; Hollis C
    BMJ Open; 2014 Dec; 4(12):e006838. PubMed ID: 25448628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol investigating the clinical utility of an objective measure of attention, impulsivity and activity (QbTest) for optimising medication management in children and young people with ADHD 'QbTest Utility for Optimising Treatment in ADHD' (QUOTA): a feasibility randomised controlled trial.
    Hall CL; James M; Brown S; Martin JL; Brown N; Selby K; Clarke J; Vijayan H; Guo B; Sayal K; Hollis C; Groom MJ
    BMJ Open; 2018 Feb; 8(2):e021104. PubMed ID: 29453304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of a computerised test of attention and activity (QbTest) on diagnostic decision-making in children and young people with suspected attention deficit hyperactivity disorder: single-blind randomised controlled trial.
    Hollis C; Hall CL; Guo B; James M; Boadu J; Groom MJ; Brown N; Kaylor-Hughes C; Moldavsky M; Valentine AZ; Walker GM; Daley D; Sayal K; Morriss R;
    J Child Psychol Psychiatry; 2018 Dec; 59(12):1298-1308. PubMed ID: 29700813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using an objective computer task (QbTest) to aid the identification of attention deficit hyperactivity disorder (ADHD) in the Children and Young People Secure Estate (CYPSE): a feasibility randomised controlled trial.
    Chitsabesan P; Hall CL; Carter LA; Reeves M; Mohammed V; Beresford B; Young S; Kraam A; Trowse S; Wilkinson-Cunningham L; Lennox C
    BMJ Open; 2022 Dec; 12(12):e064951. PubMed ID: 36526320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of user experience of an objective test (QbTest) to aid ADHD assessment and medication management: a multi-methods approach.
    Hall CL; Valentine AZ; Walker GM; Ball HM; Cogger H; Daley D; Groom MJ; Sayal K; Hollis C
    BMC Psychiatry; 2017 Feb; 17(1):66. PubMed ID: 28183284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innovations in Practice: an objective measure of attention, impulsivity and activity reduces time to confirm attention deficit/hyperactivity disorder diagnosis in children - a completed audit cycle.
    Hall CL; Selby K; Guo B; Valentine AZ; Walker GM; Hollis C
    Child Adolesc Ment Health; 2016 Sep; 21(3):175-178. PubMed ID: 32680350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Continuous Performance Testing in Adult ADHD in a Clinical Sample Using QbTest.
    Adamou M; Jones SL; Marks L; Lowe D
    J Atten Disord; 2022 Sep; 26(11):1483-1491. PubMed ID: 35255743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction to: Optimising medication management in children and young people with ADHD using a computerised test (QbTest): a feasibility randomised controlled trial.
    Williams L; Hall CL; Brown S; Guo B; James M; Franceschini M; Clarke J; Selby K; Vijayan H; Kulkarni N; Brown N; Sayal K; Hollis C; Groom MJ
    Pilot Feasibility Stud; 2021 Apr; 7(1):94. PubMed ID: 33858516
    [No Abstract]   [Full Text] [Related]  

  • 10. Working memory training in young children with ADHD: a randomized placebo-controlled trial.
    van Dongen-Boomsma M; Vollebregt MA; Buitelaar JK; Slaats-Willemse D
    J Child Psychol Psychiatry; 2014 Aug; 55(8):886-96. PubMed ID: 24628438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trial.
    Gevensleben H; Holl B; Albrecht B; Vogel C; Schlamp D; Kratz O; Studer P; Rothenberger A; Moll GH; Heinrich H
    J Child Psychol Psychiatry; 2009 Jul; 50(7):780-9. PubMed ID: 19207632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): a randomised controlled trial.
    Pelsser LM; Frankena K; Toorman J; Savelkoul HF; Dubois AE; Pereira RR; Haagen TA; Rommelse NN; Buitelaar JK
    Lancet; 2011 Feb; 377(9764):494-503. PubMed ID: 21296237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a behavioural sleep intervention on symptoms and sleep in children with attention deficit hyperactivity disorder, and parental mental health: randomised controlled trial.
    Hiscock H; Sciberras E; Mensah F; Gerner B; Efron D; Khano S; Oberklaid F
    BMJ; 2015 Jan; 350():h68. PubMed ID: 25646809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contact with the juvenile justice system in children treated with stimulant medication for attention deficit hyperactivity disorder: a population study.
    Silva D; Colvin L; Glauert R; Bower C
    Lancet Psychiatry; 2014 Sep; 1(4):278-85. PubMed ID: 26360861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of atomoxetine on executive functioning and lexical decision in attention-deficit/hyperactivity disorder and reading disorder.
    de Jong CG; Van De Voorde S; Roeyers H; Raymaekers R; Allen AJ; Knijff S; Verhelst H; Temmink AH; Smit LM; Rodriques-Pereira R; Vandenberghe D; van Welsen I; ter Schuren L; Al-Hakim M; Amin A; Vlasveld L; Oosterlaan J; Sergeant JA
    J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):699-707. PubMed ID: 20035588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the medial prefrontal cortex in impaired decision making in juvenile attention-deficit/hyperactivity disorder.
    Hauser TU; Iannaccone R; Ball J; Mathys C; Brandeis D; Walitza S; Brem S
    JAMA Psychiatry; 2014 Oct; 71(10):1165-73. PubMed ID: 25142296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing ADHD and comorbid disorders in children: the Child Behavior Checklist and the Devereux Scales of Mental Disorders.
    Eiraldi RB; Power TJ; Karustis JL; Goldstein SG
    J Clin Child Psychol; 2000 Mar; 29(1):3-16. PubMed ID: 10693028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J
    Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does placebo response differ between objective and subjective measures in children with attention-deficit/hyperactivity disorder?
    Sumner CR; Haynes VS; Teicher MH; Newcorn JH
    Postgrad Med; 2010 Sep; 122(5):52-61. PubMed ID: 20861588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.